Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ADCT ADC Therapeutics > Detailed Quotes

ADCT ADC Therapeutics

Watchlist
4.560
-0.070-1.51%
Close  02/06 16:00 ET
4.5600.0000.00%
Post Mkt Price 02/06 16:00 ET
High
4.740
Open
4.600
Turnover
1.19M
Low
4.500
Pre Close
4.630
Volume
259.49K
Market Cap
367.73M
P/E(TTM)
Loss
52wk High
17.280
Shares
80.64M
P/E(Static)
Loss
52wk Low
2.690
Float Cap
197.01M
Bid/Ask %
-33.33%
Historical High
56.590
Shs Float
43.20M
Volume Ratio
0.48
Historical Low
2.690
Dividend TTM
--
Div Yield TTM
--
P/B
3.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.60%
Amplitude
5.18%
Avg Price
4.596
Lot Size
1
Float Cap
197.01M
Bid/Ask %
-33.33%
Historical High
56.590
Shs Float
43.20M
Volume Ratio
0.48
Historical Low
2.690
Dividend TTM
--
P/B
3.51
Dividend LFY
--
Turnover Ratio
0.60%
Amplitude
5.18%
Avg Price
4.596
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
CEO: Mr. Christopher Martin
Market: NYSE
Listing Date: 05/15/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist